alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**EXHIBIT 32.2**

 

*CHIEF FINANCIAL OFFICER CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350*

 

In connection with the Quarterly Report of MedicalCV, Inc. (the “Company”)on Form 10-QSB for the quarter ended January 31, 2006, as filed withthe Securities and Exchange Commission on the date hereof (the “Report”), I,John H. Jungbauer, Vice President, Finance and Chief Financial Officer of theCompany, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuantto Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

1.             The Report fullycomplies with the requirements of Section 13(a) or 15(d) of theSecurities Exchange Act of 1934; and

 

2.             The informationcontained in the Report fairly presents, in all material respects, thefinancial condition and results of operations of the Company.

 

A signed original of this written statement required by Section 906has been provided to the Company and will be retained by the Company andfurnished to the Securities and Exchange Commission or its staff upon request.

 

 
| Dated: March 20, 2006 | By:    |   | /s/ John H. Jungbauer                                |   |
|----------------------------|--------|--------|------------------------------------------------------|--------|
|                       |   |   | John H. Jungbauer                                    |
|                       |   |   | Vice President, Finance  and Chief Financial Officer |

 

----
IN THE SUPREME COURT OF PENNSYLVANIA 

MIDDLE DISTRICT 

IN RE: APPOINTMENT OF DEPUTY 

CONSTABLE FOR HIGHSPIRE, 

PENNSYLVANIA, JOHN FRY 

PETITION OF: COMMONWEALTH OF 

PENNSYLVANIA 

No. 256 MAL 2015 

Petition for Allowance of Appeal from the 

Order of the Commonwealth Court 

ORDER 

PER CURIAM 

AND NOW, this 9th day of September, 2015, the Petition for Allowance of Appeal 

is DENIED.
#### INTERMATIC INCORPORATED, Plaintiff-Cross Appellant, v. The LAMSON & SESSIONS CO., Defendant-Appellant. *545Intermatic Incorporated, Plaintiff-Appellant, v. Lamson & Sessions Co., Defendant-Appellee.

Nos. 00-1101, 00-1116, 01-1028.

United States Court of Appeals, Federal Circuit.

DECIDED: Jan. 21, 2003.

Before NEWMAN, LOURIE, and RADER, Circuit Judges.

*ORDER*

The mandates issued on February 13, 2002, are recalled and the appeals are reinstated, following remand from the Supreme Court of the United States. *See Intermatic Inc. v. Lamson & Sessions Co.,*— U.S.-, 123 S.Ct. 549, 154 L.Ed.2d 423 (2002). The Court remanded the case “for further consideration in light of *Festo Corp. v. Shoketsu Kinzoku Kogyo Kabush-iki Co.,*535 U.S. 722, 122 S.Ct. 1831, 152 L.Ed.2d 944 (2002).” *Id.*

In *Festo,*the Court set forth guidelines and a new presumption for determining when a claim amendment may preclude a patentee from asserting infringement under the doctrine of equivalents:

> A patentee’s decision to narrow his claims through amendment may be presumed to be a general disclaimer of the territory between the original claim and the amended claim. There are some cases, however, where the amendment cannot reasonably be viewed as surrendering a particular equivalent. The equivalent may have been unforeseeable at the time of the application; the rationale underlying the amendment may bear no more than a tangential relation to the equivalent in question; or there may be some other reason suggesting that the patentee could not reasonably be expected to have described the insubstantial substitute in question. In those cases the patentee can overcome the presumption that prosecution history es-toppel bars a finding of equivalence.... The patentee must show that at the time of the amendment one skilled in the art could not reasonably be expected to have drafted a claim that would have literally encompassed the alleged equivalent.

*Festo,*122 S.Ct. at 1842 (citations omitted).

We must now consider what further action to take in this case. To help us in that determination, we order the parties to submit briefs on the following issue:

> How the Supreme Court’s criteria relate to the facts of this case, in particular, whether Intermatic can rebut the presumption that its amendment adding the phrase “within the aperture” to the claims at issue surrendered the equivalent now asserted.

The case will be decided on the basis of the briefs and motions already filed and the additional briefs addressing the questions set forth above. Such additional briefs shall be filed in accordance with Fed. Cir. R. 31 simultaneously by the parties 30 days from the date of this Order, and shall not exceed 5000 words in length.
**EXHIBIT 32.1**

 

*CHIEF EXECUTIVE OFFICER CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350*

 

In connection with the Quarterly Report of MedicalCV, Inc. (the “Company”)on Form 10-QSB for the quarter ended July 31, 2005, as filed with theSecurities and Exchange Commission on the date hereof (the “Report”), I, MarcP. Flores, President and Chief Executive Officer of the Company, certify,pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906of the Sarbanes-Oxley Act of 2002, that:

 

1.                                       the Report fully complies with the requirements of Section 13(a) or15(d) of the Securities Exchange Act of 1934; and

 

2.                                       the information contained in the Report fairly presents, inall material respects, the financial condition and results of operations of theCompany.

 

A signed original of this written statement required by Section 906has been provided to the Company and will be retained by the Company andfurnished to the Securities and Exchange Commission or its staff upon request.

 

 
| Dated:   September 14, 2005 | By:                                   | /s/ Marc P. Flores |   |
|---------------------------------------|---------------------------------------|--------------------|--------|
|                                  | Marc P. Flores                        |
|                                  | President and Chief Executive Officer |

 

----
Exhibit 32.3



Statement



Pursuant to §906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. §1350, the undersigned officer of Paperweight Development Corp. (the
Company), hereby certifies that to his knowledge:



| | (1) | the Companys Quarterly Report on Form 10-Q for the quarter ended July 3, 2005 fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities
Exchange Act of 1934, and
| | --- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | (2) | the information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------



|                       |  |  |  |  |  |                               |  |                                      
|---------------------- |  |  |  |  |  | ----------------------------- |  | -------------------------------------
|                       |  |  |  |  |  | PAPERWEIGHT DEVELOPMENT CORP.
|Dated: August 15, 2005 |  |  |  |  |  |                              
|                       |  |  |  | 
|                       |  |  |  |  |  |                               |  | /s/     MARK R. RICHARDS             
|                       |  |  |  |  |  | Name:                         |  | Mark R. Richards                     
|                       |  |  |  |  |  | Title:                        |  | President and Chief Executive Officer



This certification accompanies this
Quarterly Report on Form 10-Q pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for purposes of the Securities Exchange Act of 1934.
Exhibit 99.1



Certification of the Chief Executive Officer

Pursuant to 18 U.S.C. Section 1350,

As Adopted
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002



In connection with the Quarterly Report of Accenture SCA (the Company) on Form 10-Q for the period ended February 28, 2003 as filed with the Securities and Exchange Commission on the date hereof (the Report),
I, Joe W. Forehand, Chief Executive Officer of Accenture Ltd, the general partner of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:



| | (1) |  | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- |  | ---------------------------------------------------------------------------------------------------------------------



| | (2) |  | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | --- |  | ----------------------------------------------------------------------------------------------------------------------------------------------------



/s/     JOE W. FOREHANDJoe W. ForehandChief Executive OfficerDated:    April 14, 2003
EXHIBIT 32.1

Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

The undersigned
President and chief executive officer of First Republic Preferred Capital Corporation (the Company), hereby certifies on the date hereof pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of
2002, that the Quarterly Report on Form 10-Q for the quarter ended September 30, 2006 (the Form 10-Q), filed concurrently herewith by the Company, fully complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934, as amended, and that the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.



|                        |  |                         |  |                                      
|----------------------- |  | ----------------------- |  | -------------------------------------
|Date: November 13, 2006 |  | /s/ JAMES J. BAUMBERGER
|                        |  | Name:                   |  | James J. Baumberger                  
|                        |  | Title:                  |  | President and chief executive officer
<PAGE>   1
                                                                EXHIBIT 23(1)

                        CONSENT OF INDEPENDENT AUDITORS


     We consent to the incorporation by reference in the Registration
Statements (Form S-8 No. 33-60267 and Form S-8 No. 33-60265) pertaining to the
Assumed Options of Mykotronx, Inc., 1987 Non-Qualified Stock Option Plan, 1987
Incentive Stock Option Plan and 1990 Stock Option Plan of Rainbow Technologies,
Inc., of our report dated February 25, 1997, with respect to the consolidated
financial statements and schedule of Rainbow Technologies, Inc. included in
this Annual Report (Form 10-K) for the year ended December 31, 1996.


                                                ERNST & YOUNG LLP


Orange County, California
March 29, 1997
## Record ofContacts

DMS Docket No. FAA-200.6.-- 

# 0'-10:2... With whom outside the FAA has this proposal been discussed (e.g., ATA, RAA, ALPA, etc.)?

Or~anization Person Contacted Date ATA Joe White 3/23107 Boeing ,'eanne Mason 2/2/07
UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT
No. 95-6950
LESLIE ANTHONY WEBSTER, Plaintiff - Appellant, versus LIEUTENANT JONES; DEPUTY ATKINSON, a/k/a Deputy Atkins; SERGEANT STEWARD, Defendants - Appellees.
Appeal from the United States District Court for the Western District of Virginia, at Roanoke. James C. Turk, District Judge. (CA-94-490-R) Submitted: March 21, 1996 Decided: April 2, 1996 Before NIEMEYER and MICHAEL, Circuit Judges, and BUTZNER, Senior Circuit Judge. Affirmed by unpublished per curiam opinion. Leslie Anthony Webster, Appellant Pro Se. William Fain Rutherford, Jr., Elizabeth Kay Dillon, Kevin Scott Blair, WOODS, ROGERS, & HAZLEGROVE, Roanoke, Virginia, for Appellees. Unpublished opinions are not binding precedent in this circuit. See Local Rule 36(c).2 PER CURIAM: Appellant appeals from the district court's order denying relief on his 42 U.S.C. § 1983 (1988) complaint. We have reviewed the record and the district court's opinion and find no reversible error. Accordingly, we affirm on the reasoning of the district court. Webster v. Jones , No. CA-94-490-R (W.D. Va. May 19, 1995).We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

AFFIRMED
EXHIBIT 32.2

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In  connection  with the Annual  Report on Form 10-K/A of Travis Boats & Motors,
Inc. (the  "Company")  for the year ended  September 30, 2003, as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, Michael
B. Perrine,  Chief  Financial  Officer,  Secretary and Treasurer of the Company,
certify,  to my best  knowledge and belief,  pursuant to 18 U.S.C.  ss. 1350, as
adopted  pursuant to ss. 906 of the  Sarbanes-Oxley  Act of 2002,  that: (1) The
Report fully  complies  with the  requirements  of Section 13(a) or 15(d) of the
Securities  Exchange  Act of 1934 (15  U.S.C.  78m(a)  or  78o(d));  and (2) The
information  contained in the Report fairly presents,  in all material respects,
the financial condition and results of operations of the Company.

/s/ Michael B. Perrine
Michael B. Perrine, Chief Financial Officer, Secretary and Treasurer
January 29, 2004
Exhibit 32.1

                CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

                             AS ADOPTED PURSUANT TO

                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


     In   connection   with  the  Annual  Report  on  Form  10-K  of  CollaGenex
Pharmaceuticals,  Inc. (the "Company") for the period ended December 31, 2003 as
filed with the  Securities  and  Exchange  Commission  on the date  hereof  (the
"Report"),  the undersigned,  Colin W. Stewart,  Chief Executive  Officer of the
Company,  and Nancy C. Broadbent,  Chief Financial Officer of the Company,  each
hereby certifies, pursuant to 18 U.S.C. Section 1350, that:

     (1) The Report fully  complies  with the  requirements  of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

     (2)  The  information  contained  in the  Report  fairly  presents,  in all
material  respects,  the  financial  condition  and results of operations of the
Company.

     A signed  original of this  written  statement  required by Section 906 has
been  provided  to  CollaGenex  Pharmaceuticals,  Inc.  and will be  retained by
CollaGenex  Pharmaceuticals,  Inc. and furnished to the  Securities and Exchange
Commission or its staff upon request.



                                                     /s/ Colin W. Stewart
                                                     -------------------------
Dated:   March 15, 2004                              Colin W. Stewart
                                                     Chief Executive Officer


                                                     /s/ Nancy C. Broadbent
                                                     -------------------------
Dated:   March 15, 2004                              Nancy C. Broadbent
                                                     Chief Financial Officer
<PAGE>

                                                                   EXHIBIT 24.2



                               POWER OF ATTORNEY


The undersigned director and/or officer of Karrington Health, Inc. (the
"Company"), does hereby constitute and appoint Richard R. Slager and Thomas
J. Klimback, or either of them, my true and lawful attorneys and agents, each
with full power of substitution, to do any and all acts and things in my name
and on my behalf in my capacity as a director and/or officer of the Company
and to execute any and all instruments for me and in my name in the capacity
indicated above, which said attorneys or agents, or either of them, may deem
necessary or advisable to enable the Company to comply with the Securities
Exchange Act of 1934, as amended, and any rules, regulations and requirements
of the Securities and Exchange Commission thereunder, in connection with the
filing requirements of the Company's Annual Report on Form 10-K for the
fiscal year ended December 31, 1997 (the "1997 Form 10-K"), including
specifically but without limitation, power and authority to sign for me in my
name, in the capacity indicated above, the 1997 Form 10-K and any and all
amendments to such 1997 Form 10-K; and I do hereby ratify and confirm all
that the said attorneys and agents, or their substitute or substitutes, or
either of them, shall do or cause to be done by virtue hereof.

                                        /s/ PETE A. KLISARES
                                        Pete A. Klisares
                                        President and Chief Operating Officer
104TH CONGRESS

1ST SESSION S. 273

AN ACT

To amend section 61h–6 of title 2, United States Code.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,
2

S 273 ES

1 That section 61h–6 of title 2; The Congress, Chapter 4—

2 Officers and Employees of Senate and House of Rep3 resentatives; United States Code, is amended to read as

4 follows:

5 ‘‘§ 61h–6. Appointment of consultants by Majority

6 Leader, Minority Leader, Secretary of the

7 Senate, and Legislative Counsel of the

8 Senate; compensation

9 ‘‘(a) The Majority Leader and the Minority Leader,

10 are each authorized to appoint and fix the compensation

11 of not more than four individual consultants, on a tem12 porary or intermittent basis, at a daily rate of compensa13 tion not in excess of the per diem equivalent of the highest

14 gross rate of annual compensation which may be paid to

15 employees of a standing committee of the Senate. The Sec16 retary of the Senate is authorized to appoint and fix the

17 compensation of not more than two individual consultants,

18 on a temporary or intermittent basis, at a daily rate of

19 compensation not in excess of the per diem equivalent of

20 the highest gross rate of annual compensation which may

21 be paid to employees of a standing committee of the Sen22 ate. The Legislative Counsel of the Senate (subject to the

23 approval of the President Pro Tempore) is authorized to

24 appoint and fix the compensation of not more than two

25 consultants, on a temporary or intermittent basis, at a
3

S 273 ES

1 daily rate of compensation not in excess of that specified

2 in the first sentence of this section. The provisions of sec3 tion 8344 of title 5 shall not apply to any individual serv4 ing in a position under this authority. Expenditures under

5 this authority shall be paid from the contingent fund of

6 the Senate upon vouchers approved by the President Pro

7 Tempore, Majority Leader, Minority Leader, Secretary of

8 the Senate, or Legislative Counsel of the Senate, as the

9 case may be.

10 ‘‘(b) The Majority Leader, and the Minority Leader,

11 in appointing individuals to consultant positions under au12 thority of this section, may appoint one such individual

13 to such position at an annual rate of compensation rather

14 than at a daily rate of compensation, but such annual rate

15 shall not be in excess of the highest gross rate of annual

16 compensation which may be paid to employees of a stand17 ing committee of the Senate.’’.

Passed the Senate January 24 (legislative day, January 10), 1995.

Attest:

Secretary.
104TH CONGRESS

1ST SESSION S. 273

AN ACT

To amend section 61h–6 of title 2, United States

Code.
Order entered February 3 , 202 1

In The 

### Court of Appeals **Fifth District of Texas at Dallas** No. 05 - 19 - 01372 - CR No. 05 - 19 - 0137 3 - CR DONTE DARNELL EASTER , Appellant V. THE STATE OF TEXAS, Appellee On Ap p e al from the 203rd Jud icial District Court Dallas County, Texas Trial Court Cause No s . F 18 - 75377 - P & F18 - 75380 - P O RDER Volume 8 of t he reporter ’ s record was filed on March 30, 2020. Missing from the exhi bits is State ’ s Ex hibi t #79 , a DVD of defendant ’ s interview with police. We ORDER cour t reporter Crystal Brown to file, within fourtee n days o f the date of this order, a supplemental reporter ’ s record containing a play able copy of State ’ s E xhibit #79. / s/ LANA MYERS JUSTICE
```

[Congressional Bills 104th Congress]
[From the U.S. Government Publishing Office]
[S. 369 Enrolled Bill (ENR)]

        S.369

                       One Hundred Fourth Congress

                                 of the

                        United States of America

                          AT THE FIRST SESSION

         Begun and held at the City of Washington on Wednesday,
  the fourth day of January, one thousand nine hundred and ninety-five

                                 An Act

 
    To designate the Federal Courthouse in Decatur, Alabama, as the 
    ``Seybourn H. Lynne Federal Courthouse'', and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. DESIGNATION.

    The Federal Courthouse in Decatur, Alabama, is designated as the 
``Seybourn H. Lynne Federal Courthouse''.

SEC. 2. LEGAL REFERENCES.

    Any reference in any law, regulation, document, record, map, or 
other paper of the United States to the building referred to in section 
1 is deemed to be a reference to the Seybourn H. Lynne Federal 
Courthouse.

                               Speaker of the House of Representatives.

                            Vice President of the United States and    
                                               President of the Senate.
```
**Exhibit 23.2**

 

INDEPENDENT AUDITORS’ CONSENT

 

We consent to the incorporationby reference in the Registration Statements No. 333-77625 and 333-81962 onForms S-8 of On-Site Sourcing, Inc. of our report dated January 31, 2002,relating to the balance sheet of On-Site Sourcing, Inc. as of December 31, 2001and the related statements of income, stockholders’ equity and cash flows forthe years ended December 31, 2001 and 2000, which report appears in this AnnualReport of On-Site Sourcing, Inc.

 

 
| /s/ Reznick  Fedder & Silverman |   |
|-------------------------------------|--------|
|                                |
| Bethesda,  Maryland                 |
| March 25,  2003                     |

 

----
EXHIBIT 32  CERTIFICATION PURSUANT TO 18 U.S.C. SECTION1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002  In connection with the Quarterly Report of instaCare Corp. (the "Company") on Form 10-Q for the period ended March 31, 2010, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Keith Berman, Principal Executive Officer and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:   (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and   (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.   /s/ Keith Berman  Keith Berman


| |                                
| | -------------------------------
| | Principal Executive Officer and

Chief Financial Officer  May 17, 2010